T8 Influenza: From Correlates of Protection to Next Generation Vaccines
|
|
|
|
Florian Krammer, Aubree Gordon and Davide Corti
|
|
Jan 1 - 4
|
Y3 Biomolecular Condensates: Phase-Separated Organizers of Cellular Biochemistry
|
|
|
|
J. Paul Taylor and Geraldine Seydoux
|
|
Jan 1 - 4
|
Y4 Neuronal Cell Biology: A Biology of Extremes
|
|
|
|
Timothy A. Ryan and Erin M. Schuman
|
|
Jan 1 - 4
|
F1 Long COVID and Post Acute Sequalae of SARS CoV 2 (PASC): Pathogenesis and Treatment
|
May. 24
|
May. 24
|
Jun. 27
|
Steven G. Deeks, Michael J. Holtzman, Resia Pretorius and Catherine A. Blish
|
|
Aug 27 - 30
|
F2 Transposable Elements at the Crossroads of Evolution, Health and Disease
|
Jun. 1
|
Jun. 1
|
Jul. 6
|
Kathleen H. Burns, Harmit S. Malik and Irina Arkhipova
|
|
Sep 3 - 6
|
EK1 Next-Generation Nanomedicine
|
|
Aug. 30
|
|
Philip L. Felgner, Anna K. Blakney and Norbert Pardi
|
|
Sep 6 - 8
|
F6 Vaccinology During and After COVID-19
|
Jun. 15
|
Jun. 15
|
Jul. 19
|
Bali Pulendran, Robert A. Seder and Gagandeep Kang
|
|
Sep 17 - 20
|
F3 Immunity and Aging
|
Jun. 28
|
Jun. 28
|
Aug. 1
|
Danica Chen, Sun Hur and Joan Mannick
|
|
Oct 1 - 4
|
G5 Cilia in Development and Disease
|
|
|
|
Maxence V. Nachury, Piali Sengupta and Gaia Pigino
|
|
Oct 1 - 4
|
H4 Vaccinology
|
|
|
|
|
|
Oct 1 - 4
|
J1 B Cells and Tertiary Lymphoid Structures: Emerging Targets in Cancer Therapeutics
|
Jun. 28
|
Jun. 28
|
Aug. 1
|
Tullia C. Bruno, Brad H. Nelson, Daniel Hollern and Marie-Caroline Dieu-Nosjean
|
|
Oct 1 - 4
|
J2 T and B Cell Collaboration in Germinal Centers and Beyond
|
Jun. 28
|
Jun. 28
|
Aug. 1
|
Shane Crotty, Michela Locci and Jennifer L. Gommerman
|
|
Oct 1 - 4
|
J3 Circulating Metabolic Intermediates as Fuels and Signals
|
Jul. 6
|
Jul. 6
|
Aug. 8
|
Sven Enerbäck, Joshua D. Rabinowitz and Sarah-Maria Fendt
|
|
Oct 8 - 11
|
J4 Mechanisms of Microbiota-Immune Interactions-Towards the Next Decade
|
Jul. 6
|
Jul. 6
|
Aug. 8
|
Jorge Henao-Mejia, Eran Elinav and Lora V. Hooper
|
|
Oct 8 - 11
|
F4 COVID-19 and the World Response: Are We Prepared for the Next Pandemic?
|
|
|
|
Nevan J. Krogan, Ana Fernandez-Sesma, John A. T. Young and Jacqueline M. Fabius
|
|
Nov 12 - 16
|
J5 Autophagy and Disease
|
Aug. 30
|
Aug. 30
|
Oct. 3
|
Eric H. Baehrecke and Anastasia Henry
|
|
Dec 3 - 6
|
J6 Ubiquitin Biology and Disease
|
Aug. 30
|
Aug. 30
|
Oct. 3
|
Ivan Dikic and Cynthia Wolberger
|
|
Dec 3 - 6
|
J7 RNA Modifications in Health and Disease
|
Sep. 7
|
Sep. 25
|
Oct. 12
|
Eric A. Miska, Ramesh S. Pillai and Eva Maria Novoa Pardo
|
|
Dec 12 - 15
|
J8 Regulatory RNAs: Emerging Mechanisms
|
Sep. 7
|
Sep. 25
|
Oct. 12
|
Mitchell Guttman, Phillip D. Zamore and Maite Huarte
|
|
Dec 12 - 15
|
G8 Next-Generation Therapeutic Development in Inflammatory Bowel Disease
|
|
|
|
Dermot P. B. McGovern, Séverine Vermeire, Ailsa Hart and Thaddeus S. Stappenbeck
|
|
Jan 1 - 4
|
H8 Neuropsychiatric and Neurodevelopmental Disorders: Harnessing Rare Variants
|
|
|
|
Jennifer G. Mulle, Audrey Thurm, Christa L. Martin and Carrie E. Bearden
|
|
Jan 1 - 4
|
W7 Eukaryotic Gene Regulation: New Mechanisms and Technologies
|
|
|
|
Shannon M. Lauberth, Lu Bai and Laura A. Banaszynski
|
|
Jan 1 - 4
|
Q1 Exercise Biology: Signaling, Mechanisms and Benefits
|
Oct. 24
|
Oct. 24
|
Nov. 14
|
Jeffrey F. Horowitz, Laurie J. Goodyear and Karyn A. Esser
|
|
Jan 14 - 17
|
Q2 Mammalian Somatosensation: Mechanisms of Itch, Touch, Pain and Interoception in Health and Disease
|
Oct. 24
|
Oct. 24
|
Nov. 14
|
Diana Bautista, Rebecca P. Seal and Ishmail John Abdus-Saboor
|
|
Jan 14 - 17
|
A1 Inhibitory Receptors in Immune Homeostasis, Disease and Therapy
|
Oct. 25
|
Oct. 25
|
Nov. 16
|
Linde Meyaard, Jonathon D. Sedgwick, Carla V. Rothlin and Alex McCarthy
|
|
Jan 16 - 19
|
A2 Single-Cell Biology: Tissue Genomics, Technologies and Disease
|
Oct. 26
|
Oct. 26
|
Nov. 16
|
Jason Buenrostro, Lacramioara Bintu and Fei Chen
|
|
Jan 21 - 24
|
Q3 Targeted Protein Degradation
|
Oct. 26
|
Oct. 26
|
Nov. 16
|
James E. Bradner, Eric S. Fischer and Brenda A. Schulman
|
|
Jan 21 - 24
|
Q4 Proximity Based Therapeutics
|
Oct. 26
|
Oct. 26
|
Nov. 16
|
Ryan Potts and Michelle R. Arkin
|
|
Jan 21 - 24
|
Q5 Emerging Cellular Therapies
|
Oct. 30
|
Oct. 30
|
Nov. 21
|
Dan S. Kaufman, Kiem and Sonja Schrepfer
|
|
Jan 22 - 25
|
Q6 Stem Cells and Regeneration
|
Oct. 30
|
Oct. 30
|
Nov. 21
|
Heinrich Jasper and Emmanuelle Passegué
|
|
Jan 22 - 25
|
Q7 Delivery of Nucleic Acid Therapeutics
|
Nov. 2
|
Nov. 2
|
Nov. 21
|
Daniel J. Siegwart and Kathryn Whitehead
|
|
Jan 22 - 25
|
Q8 Precision Genome Engineering
|
Nov. 2
|
Nov. 2
|
Nov. 21
|
Morgan Maeder, Benjamin P. Kleinstiver and Kiran Musunuru
|
|
Jan 22 - 25
|
A3 Myeloid Cell Diversity: From Fundamental Biology to Disease States
|
Oct. 24
|
Oct. 24
|
Nov. 28
|
Andrés Hidalgo, Daniela F. Quail and Lai Guan Ng
|
|
Jan 28 - 31
|
B1 Epigenetic Mechanisms and Cancer Treatment
|
Oct. 31
|
Oct. 31
|
Dec. 5
|
Tony Kouzarides, Rab K. Prinjha and Marisa S. Bartolomei
|
|
Feb 4 - 7
|
X3 Cardiometabolic Diseases: The Role of Ethnic Diversity in Precision Medicine
|
Dec. 1
|
Dec. 6
|
Dec. 6
|
Paul W. Franks, Ewan Pearson and Karin Conde-Knape
|
|
Feb 4 - 7
|
X4 Obesity Causes and Consequences
|
Oct. 31
|
Oct. 31
|
Dec. 5
|
Giles S.H. Yeo, Karine Clément and Murielle M. Véniant-Ellison
|
|
Feb 4 - 7
|
T4 Stem Cell Models for Embryology
|
Nov. 2
|
Nov. 22
|
Dec. 7
|
Aryeh Warmflash and Magdalena D. Zernicka-Goetz
|
|
Feb 6 - 8
|
B2 Systemic Autoimmune and Autoinflammatory Diseases
|
Nov. 1
|
Nov. 21
|
Dec. 7
|
Mariana J. Kaplan, Georg Schett and Carola G. Vinuesa
|
|
Feb 8 - 11
|
T1 CANCELLED: Neurobiology of Reward and Addiction
|
Nov. 30
|
Nov. 30
|
Dec. 12
|
Thomas Kash, Camilla Bellone, Michael Taffe and Ziva Cooper
|
|
Feb 12 - 14
|
B3 Tumor Metabolism
|
Nov. 7
|
Nov. 7
|
Dec. 12
|
Gina DeNicola, Rushika M. Perera and David B. Shackelford
|
|
Feb 12 - 15
|
X5 Mitochondria Signaling and Disease
|
Nov. 8
|
Nov. 8
|
Dec. 13
|
Heidi M. McBride and Timothy Wai
|
|
Feb 12 - 15
|
X6 Organelle Membrane Contact Sites in Health and Disease
|
Nov. 28
|
Nov. 28
|
Dec. 13
|
Gia K. Voeltz and Jodi Nunnari
|
|
Feb 12 - 15
|
X7 Fungal Pathogens: Emerging Threats and Future Challenges
|
Nov. 9
|
Nov. 9
|
Dec. 14
|
Michail Lionakis, Sarah L. Gaffen and Mari L. Shinohara
|
|
Feb 18 - 21
|
X8 Regulation of Barrier Immunity
|
Nov. 10
|
Nov. 10
|
Dec. 15
|
David Artis, Yasmine Belkaid, Fiona M. Powrie and Kenya Honda
|
|
Feb 18 - 21
|
B4 Hematopoiesis
|
Nov. 29
|
Nov. 29
|
Dec. 19
|
Trista E. North, Michael G. Kharas and Nina Cabezas-Wallscheid
|
|
Feb 25 - 28
|
C1 MASH and Fibrosis: From Molecular Phenotypes to Precision Therapeutics
|
Nov. 28
|
Dec. 14
|
Jan. 4
|
Stefano Romeo, Michael Charlton, Silvia C. Sookoian and Gregory Tesz
|
|
Mar 3 - 6
|
T2 Unraveling Vascular Layers to Understand Human Disease
|
Jan. 2
|
Jan. 2
|
Jan. 16
|
Rachel J. Roth Flach and Stephanie Wengert Watts
|
|
Mar 17 - 19
|
C2 Cancer Immunotherapy: Beyond Immune Checkpoint Blockade and Overcoming Resistance
|
Dec. 7
|
Dec. 7
|
Jan. 17
|
James P. Allison, Andrea Schietinger, Antoni Ribas and Padmanee Sharma
|
|
Mar 17 - 20
|
K2 Microbiota and Cancer Immunity
|
Dec. 26
|
Dec. 26
|
Jan. 17
|
Giorgio Trinchieri, Jenny P.Y. Ting, Hsing-Jien Kung and Shie-Liang Hsieh
|
|
Mar 17 - 20
|
C3 Immunometabolism: From Mechanisms to Pathways to Therapies
|
Dec. 7
|
Dec. 7
|
Jan. 17
|
Luke A. J. O'Neill, Evanna Mills and Erika L. Pearce
|
|
Mar 18 - 21
|
C4 Tuberculosis: The Host-Pathogen Interface
|
Dec. 19
|
Dec. 19
|
Jan. 24
|
Marcel A. Behr, Lalita Ramakrishnan and Kevin B. Urdahl
|
|
Mar 24 - 27
|
K1 HIV and (Re)Emerging Viruses: Aligning Lessons Across Pandemics
|
Jan. 17
|
Jan. 17
|
Feb. 7
|
Melanie M. Ott, Priti Kumar, Olivier Schwartz and Alex Sigal
|
|
Apr 8 - 11
|
Z1 Innate Immunity Across the Molecular, Cellular, Tissue and Therapeutic
|
Jan. 18
|
Jan. 18
|
Feb. 8
|
Kate L. Jeffrey, Ramnik Xavier and Xu Zhou
|
|
Apr 9 - 12
|
Z2 Systems and Engineering Immunology: Advancing Immunological Insights in Health and Disease
|
Jan. 18
|
Jan. 18
|
Feb. 8
|
John Tsang, Shannon J Turley and Alex Marson
|
|
Apr 9 - 12
|
C5 Cardiovascular Epigenetics and Gene Regulation
|
Jan. 23
|
Jan. 23
|
Feb. 14
|
Roger Foo, Federica Accornero and Enzo R. Porrello
|
|
Apr 15 - 18
|
EK2 AI in Biomedicine
|
|
Mar. 20
|
|
Thomas Hartung, Weida Tong and Yvonne Will
|
|
May 1 - 3
|
T3 Cachexia and Wasting Syndrome in Cancer and Chronic Diseases
|
Feb. 14
|
Feb. 14
|
Mar. 5
|
Bei B. Zhang and Teresa Zimmers
|
|
May 5 - 7
|
C6 Antibodies as Drugs: The Art in Antibody Engineering
|
Feb. 13
|
Feb. 13
|
Mar. 5
|
Laura M. Walker and Paul W. H. I. Parren
|
|
May 5 - 8
|
C7 Myeloid Targeting Strategies for Cancer Treatment
|
Jan. 31
|
Jan. 31
|
Mar. 6
|
Miriam Merad and Matthew F. Krummel
|
|
May 6 - 9
|
Z3 Neurodegenerative Diseases
|
Feb. 29
|
Feb. 29
|
Apr. 4
|
Leonard Petrucelli, Stacie Weninger and Soyon Hong
|
|
Jun 3 - 6
|
Z4 Neuroimmune Interactions: Nervous System and Immune Cell Heterogeneity in Health and Disease
|
Feb. 29
|
Feb. 29
|
Apr. 4
|
Nicola J. Allen, Anna Victoria Molofsky and Francisco J. Quintana
|
|
Jun 3 - 6
|